103 related articles for article (PubMed ID: 27401842)
1. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
[TBL] [Abstract][Full Text] [Related]
2. Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
Bukowski A; Hoyo C; Vielot NA; Graff M; Kosorok MR; Brewster WR; Maguire RL; Murphy SK; Nedjai B; Ladoukakis E; North KE; Smith JS
BMC Cancer; 2023 Nov; 23(1):1072. PubMed ID: 37932662
[TBL] [Abstract][Full Text] [Related]
3. Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma.
Ben-Dayan MM; Ow TJ; Belbin TJ; Wetzler J; Smith RV; Childs G; Diergaarde B; Hayes DN; Grandis JR; Prystowsky MB; Schlecht NF
Cancer Med; 2017 Feb; 6(2):397-407. PubMed ID: 28102032
[TBL] [Abstract][Full Text] [Related]
4. ANRIL Promoter DNA Methylation: A Perinatal Marker for Later Adiposity.
Lillycrop K; Murray R; Cheong C; Teh AL; Clarke-Harris R; Barton S; Costello P; Garratt E; Cook E; Titcombe P; Shunmuganathan B; Liew SJ; Chua YC; Lin X; Wu Y; Burdge GC; Cooper C; Inskip HM; Karnani N; Hopkins JC; Childs CE; Chavez CP; Calder PC; Yap F; Lee YS; Chong YS; Melton PE; Beilin L; Huang RC; Gluckman PD; Harvey N; Hanson MA; Holbrook JD; ; Godfrey KM
EBioMedicine; 2017 May; 19():60-72. PubMed ID: 28473239
[TBL] [Abstract][Full Text] [Related]
5. Methylation patterns of the IFN-γ gene in cervical cancer tissues.
Ma D; Jiang C; Hu X; Liu H; Li Q; Li T; Yang Y; Li O
Sci Rep; 2014 Sep; 4():6331. PubMed ID: 25208560
[TBL] [Abstract][Full Text] [Related]
6. Molecular monitoring by CDKN2A/p16INK4A and RB1 gene methylation in breast cancer.
Queiroz LF; Silva MSDME; Rosman FC; Rosas SLB; Souza HSP; Carvalho MDGDC
Rev Assoc Med Bras (1992); 2024; 70(4):e20231358. PubMed ID: 38716944
[TBL] [Abstract][Full Text] [Related]
7. Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis.
Singh AN; Sharma N
Onco Targets Ther; 2017; 10():4925-4933. PubMed ID: 29066912
[TBL] [Abstract][Full Text] [Related]
8. Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma.
Thibodeau ML; Bonakdar M; Zhao E; Mungall KL; Reisle C; Zhang W; Bye MH; Thiessen N; Bleile D; Mungall AJ; Ma YP; Jones MR; Renouf DJ; Lim HJ; Yip S; Ng T; Ho C; Laskin J; Marra MA; Schrader KA; Jones SJM
NPJ Precis Oncol; 2018; 2(1):8. PubMed ID: 29872726
[TBL] [Abstract][Full Text] [Related]
9. In situ expressions of protein 16 (p16
Viloria ME; Bravo J; Carrero Y; Mosquera JA
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():303-307. PubMed ID: 30059872
[TBL] [Abstract][Full Text] [Related]
10. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract][Full Text] [Related]
11. The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis.
Li J; Zhou C; Zhou H; Bao T; Gao T; Jiang X; Ye M
Ther Clin Risk Manag; 2016; 12():1249-60. PubMed ID: 27574435
[TBL] [Abstract][Full Text] [Related]
12. Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome.
Soltan MA; Alhanshani AA; Shati AA; Alqahtani YA; Alshaya DS; Alharthi J; Altalhi SA; Fayad E; Zaki MSA; Eid RA
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626750
[TBL] [Abstract][Full Text] [Related]
13. Genomic Risk Factors for Cervical Cancer.
Ramachandran D; Dörk T
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680286
[TBL] [Abstract][Full Text] [Related]
14. An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.
Han Y; Ji L; Guan Y; Ma M; Li P; Xue Y; Zhang Y; Huang W; Gong Y; Jiang L; Wang X; Xie H; Zhou B; Wang J; Wang J; Han J; Deng Y; Yi X; Gao F; Huang J
Clin Transl Med; 2021 Jul; 11(7):e498. PubMed ID: 34323415
[TBL] [Abstract][Full Text] [Related]
15. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
[TBL] [Abstract][Full Text] [Related]
16. Screening and Identification of Differentially Expressed Genes Expressed among Left and Right Colon Adenocarcinoma.
Han J; Zhang X; Yang Y; Feng L; Wang GY; Zhang N
Biomed Res Int; 2020; 2020():8465068. PubMed ID: 32420374
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment.
Zhu H; Zhu H; Tian M; Wang D; He J; Xu T
Front Genet; 2020; 11():347. PubMed ID: 32328088
[TBL] [Abstract][Full Text] [Related]
18. Methylation profiling in promoter sequences of
Delmonico L; Silva Magalhães Costa MA; Gomes RJ; De Oliveira Vieira P; Da Silva ABP; Fournier MV; Scherrer LR; De Azevedo CM; Ornellas MHF; Alves G
Oncol Lett; 2020 Apr; 19(4):3003-3010. PubMed ID: 32218857
[TBL] [Abstract][Full Text] [Related]
19. Host proteome linked to HPV E7-mediated specific gene hypermethylation in cancer pathways.
Na Rangsee N; Yanatatsaneejit P; Pisitkun T; Somparn P; Jintaridth P; Topanurak S
Infect Agent Cancer; 2020; 15():7. PubMed ID: 32025240
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
